Document is current
Any future updates will be listed below
-
Authors
Scarborough, Jessica A. http://orcid.org/0000-0002-5365-5735
Eschrich, Steven A.
Torres-Roca, Javier
Dhawan, Andrew
Scott, Jacob G. http://orcid.org/0000-0003-2971-7673
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (5R37CA244613-02, 1F30CA257076, T32GM007250)
American Cancer Society (RSG-20-096-01)
- License Information
-
More Information
Article History
Received: 30 September 2022
Accepted: 21 March 2023
First Online: 19 April 2023
Change Date: 24 May 2023
Change Type: Update
Change Details: In the original version of this manuscript, Supplementary Files 1, 2, 3, and 4 were accidentally omitted. They have now been added and the original article has been updated.
Competing interests
: J.A.S., A.D., and J.G.S. have a patent application (No. 17587410) filed for the genes included in CisSig and a methodology for converting said genes into a cisplatin response score.
